Related Experiment Videos

Chloral hydrate sedation in neonates and infants--clinical and pharmacologic considerations

L D Reimche1, K Sankaran, K W Hindmarsh

  • 1Perinatal Research Laboratory, College of Pharmacy, University of Saskatchewan, Saskatoon, Canada.

Developmental Pharmacology and Therapeutics
|January 1, 1989
PubMed

Insights

Chloral hydrate metabolism in infants can lead to harmful metabolite accumulation. Caution and monitoring are advised for preterm infants due to potential bilirubin competition.

Area of Science:

  • Pharmacology
  • Neonatal Medicine
  • Toxicology

Background:

  • Chloral hydrate is a long-used sedative with limited data on infant metabolism.
  • Understanding chloral hydrate's metabolic fate in neonates and infants is crucial.

Purpose of the Study:

  • To quantify chloral hydrate and its metabolites in infants.
  • To investigate potential adverse effects and drug interactions in this population.

Main Methods:

  • Quantification of chloral hydrate and metabolites in 12 neonates and 2 infants.
  • Analysis of metabolite accumulation and potential competition for hepatic glucuronidation.

Main Results:

  • Trichloroacetic acid and trichloroethanol accumulated in compromised infants.
  • Indirect evidence suggests trichloroethanol competes with bilirubin for hepatic glucuronidation in preterm infants.

Conclusions:

  • Multiple chloral hydrate doses require caution in preterm infants.
  • Frequent monitoring of serum bilirubin is recommended.
  • The detailed metabolism of chloral hydrate is discussed.

Related Concept Videos